Acumen Pharmaceuticals, Inc.ABOSNASDAQ
LOADING
|||
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 35.29% |
| Q2 2025 | -41.67% |
| Q1 2025 | 22.58% |
| Q4 2024 | -24.00% |
| Q3 2024 | -47.06% |
| Q2 2024 | -36.00% |
| Q1 2024 | 10.71% |
| Q4 2023 | -16.67% |
| Q3 2023 | 14.29% |
| Q2 2023 | -21.74% |
| Q1 2023 | 32.35% |
| Q4 2022 | -36.00% |
| Q3 2022 | -4.17% |
| Q2 2022 | -9.09% |
| Q1 2022 | 0.00% |
| Q4 2021 | -120.00% |
| Q3 2021 | 93.71% |
| Q2 2021 | -117.81% |
| Q1 2021 | -2665.15% |
| Q4 2020 | 69.62% |
| Q3 2020 | -22.39% |
| Q2 2020 | 0.56% |
| Q1 2020 | 0.00% |